1. Home
  2. UBX vs ATER Comparison

UBX vs ATER Comparison

Compare UBX & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • ATER
  • Stock Information
  • Founded
  • UBX 2009
  • ATER 2014
  • Country
  • UBX United States
  • ATER United States
  • Employees
  • UBX N/A
  • ATER N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • ATER Home Furnishings
  • Sector
  • UBX Health Care
  • ATER Consumer Discretionary
  • Exchange
  • UBX Nasdaq
  • ATER Nasdaq
  • Market Cap
  • UBX 13.9M
  • ATER 15.5M
  • IPO Year
  • UBX 2018
  • ATER N/A
  • Fundamental
  • Price
  • UBX $0.78
  • ATER $1.66
  • Analyst Decision
  • UBX Strong Buy
  • ATER
  • Analyst Count
  • UBX 3
  • ATER 0
  • Target Price
  • UBX $4.67
  • ATER N/A
  • AVG Volume (30 Days)
  • UBX 521.0K
  • ATER 243.8K
  • Earning Date
  • UBX 08-05-2025
  • ATER 08-07-2025
  • Dividend Yield
  • UBX N/A
  • ATER N/A
  • EPS Growth
  • UBX N/A
  • ATER N/A
  • EPS
  • UBX N/A
  • ATER N/A
  • Revenue
  • UBX N/A
  • ATER $94,191,000.00
  • Revenue This Year
  • UBX N/A
  • ATER N/A
  • Revenue Next Year
  • UBX N/A
  • ATER $7.48
  • P/E Ratio
  • UBX N/A
  • ATER N/A
  • Revenue Growth
  • UBX N/A
  • ATER N/A
  • 52 Week Low
  • UBX $0.66
  • ATER $1.22
  • 52 Week High
  • UBX $3.10
  • ATER $3.84
  • Technical
  • Relative Strength Index (RSI)
  • UBX 48.12
  • ATER 58.30
  • Support Level
  • UBX $0.67
  • ATER $1.34
  • Resistance Level
  • UBX $0.83
  • ATER $1.52
  • Average True Range (ATR)
  • UBX 0.09
  • ATER 0.13
  • MACD
  • UBX 0.01
  • ATER 0.05
  • Stochastic Oscillator
  • UBX 24.67
  • ATER 88.00

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About ATER Aterian Inc.

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.

Share on Social Networks: